These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34357699)

  • 1. Disease characterization of people with cystic fibrosis and a minimal function mutation: Data from the Italian registry.
    Salvatore D; Carnovale V; Majo F; Padoan R; Quattrucci S; Salvatore M; Taruscio D; Amato A; Ferrari G; Campagna G
    Pediatr Pulmonol; 2021 Oct; 56(10):3232-3241. PubMed ID: 34357699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Italian Cystic Fibrosis Registry (ICFR). Report 2021-2022].
    Campagna G; Amato A; Majo F; Ferrari G; Quattrucci S; Padoan R; Floridia G; Salvatore D; Carnovale V; Puppo Fornaro G; Taruscio D; Salvatore M;
    Epidemiol Prev; 2024; 48(2 Suppl 2):1-41. PubMed ID: 38742380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease burden in people with cystic fibrosis heterozygous for F508del and a minimal function mutation.
    Sawicki GS; Van Brunt K; Booth J; Bailey E; Millar SJ; Konstan MW; Flume PA
    J Cyst Fibros; 2022 Jan; 21(1):96-103. PubMed ID: 34289939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Italian Cystic Fibrosis Registry (ICFR). Report 2015-2016].
    Giordani B; Amato A; Majo F; Ferrari G; Quattrucci S; Minicucci L; Padoan R; Floridia G; Salvatore D; Carnovale V; Puppo Fornaro G; Taruscio D; Salvatore M;
    Epidemiol Prev; 2019; 43(4S1):1-36. PubMed ID: 31370382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Italian Cystic Fibrosis Registry (ICFR). Report 2017-2018].
    Campagna G; Amato A; Majo F; Ferrari G; Quattrucci S; Padoan R; Floridia G; Salvatore D; Carnovale V; Puppo Fornaro G; Taruscio D; Salvatore M;
    Epidemiol Prev; 2021; 45(3 Suppl 1):1-37. PubMed ID: 34132083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic fibrosis with non-G551D gating mutations in Italy: Epidemiology and clinical characteristics.
    Salvatore D; Carnovale V; Majo F; Padoan R; Salvatore M; Taruscio D; Amato A; Ferrari G; Campagna G
    Pediatr Pulmonol; 2021 Feb; 56(2):442-449. PubMed ID: 33219628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geographic distribution and phenotype of European people with cystic fibrosis carrying A1006E mutation.
    Mondejar-Lopez P; Zolin A; Garcia-Marcos PW; Pastor-Vivero MD; Rosa-Silvestre M; de Asis Sanchez-Martinez F; Salvatore D; Cimino G; Majo F; Sole-Jover A; Asensio de la Cruz O; Calderazzo MA; Pizzamiglio G; Castillo-Corullon S; Alvarez-Fernandez A; Gartner S; Padoan R; Carnovale V; Salvatore M; Moya-Quiles MR; Orenti A; Glover G; Sanchez-Solis M
    Respir Med; 2022 Feb; 192():106736. PubMed ID: 35032736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Italian Cystic Fibrosis Registry (ICFR). Report 2019-2020].
    Campagna G; Amato A; Majo F; Ferrari G; Quattrucci S; Padoan R; Floridia G; Salvatore D; Carnovale V; Puppo Fornaro G; Taruscio D; Salvatore M;
    Epidemiol Prev; 2022; 46(4 Suppl 2):1-38. PubMed ID: 36102313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Italian Cystic Fibrosis Registry. Report 2011-2014].
    Giordani B; Amato A; Majo F; Ferrari G; Quattrucci S; Minicucci L; Padoan R; Floridia G; Puppo Fornaro G; Taruscio D; Salvatore M;
    Epidemiol Prev; 2018; 42(1S1):1-32. PubMed ID: 29506377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with cystic fibrosis having a residual function mutation: Data from the Italian registry.
    Salvatore D; Padoan R; Buzzetti R; Amato A; Giordani B; Ferrari G; Majo F
    Pediatr Pulmonol; 2019 Feb; 54(2):150-157. PubMed ID: 30561903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric population with cystic fibrosis in the centre of Portugal: candidates for new therapies.
    Roda J; Teixeira T; Ai Silva I; Silva TR; Ferreira R; Amaral MD; Oliveira G
    J Pediatr (Rio J); 2022; 98(2):212-217. PubMed ID: 34252371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burden of cystic fibrosis in children <12 years of age prior to the introduction of CFTR modulator therapies.
    Bresnick K; Arteaga-Solis E; Millar SJ; Laird G; LeCamus C
    BMJ Open Respir Res; 2021 Dec; 8(1):. PubMed ID: 34857524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsense mutations accelerate lung disease and decrease survival of cystic fibrosis children.
    Orenti A; Pranke I; Faucon C; Varilh J; Hatton A; Golec A; Dehillotte C; Durieu I; Reix P; Burgel PR; Grenet D; Tasset C; Gachelin E; Perisson C; Lepissier A; Dreano E; Tondelier D; Chevalier B; Weiss L; Kiefer S; Laurans M; Chiron R; Lemonnier L; Marguet C; Jung A; Edelman A; Kerem BS; Girodon E; Taulan-Cadars M; Hinzpeter A; Kerem E; Naehrlich L; Sermet-Gaudelus I;
    J Cyst Fibros; 2023 Nov; 22(6):1070-1079. PubMed ID: 37422433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tezacaftor/ivacaftor in people with cystic fibrosis heterozygous for minimal function CFTR mutations.
    Munck A; Kerem E; Ellemunter H; Campbell D; Wang LT; Ahluwalia N; Owen CA; Wainwright C
    J Cyst Fibros; 2020 Nov; 19(6):962-968. PubMed ID: 32546431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
    Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
    Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of CFTR gene mutations and cystic fibrosis incidence in the Ecuadorian population.
    Valle EP; Burgos RI; Valle JR; Egas Béjar D; Ruiz-Cabezas JC
    Invest Clin; 2007 Mar; 48(1):91-8. PubMed ID: 17432547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Italian Cystic Fibrosis Register - Report 2010].
    Amato A; Ferrigno L; Salvatore M; Toccaceli V;
    Epidemiol Prev; 2016; 40(2 Suppl 2):1-47. PubMed ID: 27291389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations in a Cohort of Patients Residing in Palestine.
    Siryani I; Jama M; Rumman N; Marzouqa H; Kannan M; Lyon E; Hindiyeh M
    PLoS One; 2015; 10(7):e0133890. PubMed ID: 26208274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of disease-causing CFTR variants in state newborn screening programs.
    McGarry ME; Ren CL; Wu R; Farrell PM; McColley SA
    Pediatr Pulmonol; 2023 Feb; 58(2):465-474. PubMed ID: 36237137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
    Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
    J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.